Natco Pharma [NATCOPHARM] vs Neuland Laboratories [NEULANDLAB] Detailed Stock Comparison

Natco Pharma

NSE
Loading...

Neuland Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Natco Pharma wins in 14 metrics, Neuland Laboratories wins in 6 metrics, with 0 ties. Natco Pharma appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricNatco PharmaNeuland LaboratoriesBetter
P/E Ratio (TTM)9.03109.62Natco Pharma
Price-to-Book Ratio2.0112.71Natco Pharma
Debt-to-Equity Ratio3.6710.31Natco Pharma
PEG Ratio-0.32-1.28Neuland Laboratories
EV/EBITDA6.7684.10Natco Pharma
Profit Margin (TTM)38.62%13.24%Natco Pharma
Operating Margin (TTM)38.63%4.88%Natco Pharma
EBITDA Margin (TTM)38.63%4.88%Natco Pharma
Return on Equity24.77%17.06%Natco Pharma
Return on Assets (TTM)21.85%11.93%Natco Pharma
Free Cash Flow (TTM)$11.85B$1.11BNatco Pharma
Dividend Yield0.92%0.08%Natco Pharma
1-Year Return-39.55%17.45%Neuland Laboratories
Price-to-Sales Ratio (TTM)3.4914.68Natco Pharma
Enterprise Value$132.71B$195.55BNeuland Laboratories
EV/Revenue Ratio3.0214.70Natco Pharma
Gross Profit Margin (TTM)82.47%47.77%Natco Pharma
Revenue per Share (TTM)$245$1,037Neuland Laboratories
Earnings per Share (Diluted)$94.75$137.75Neuland Laboratories
Beta (Stock Volatility)0.190.01Neuland Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Natco Pharma vs Neuland Laboratories Stock Performance Analysis

Loading Price Chart...

Natco Pharma
Neuland Laboratories
Natco Pharma Stock Overview | Neuland Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Natco Pharma-1.39%-0.36%-2.36%-1.73%2.93%-38.87%
Neuland Laboratories-1.28%-7.01%11.06%22.65%26.15%5.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Natco Pharma-39.55%41.00%-8.92%74.95%1,379.65%3,349.92%
Neuland Laboratories17.45%1,001.92%1,175.35%1,614.17%15,382.84%17,483.10%

News Based Sentiment: Natco Pharma vs Neuland Laboratories

Natco Pharma

News based Sentiment: MIXED

September presented a mixed bag for Natco Pharma. While the positive FDA inspection is a significant win, disappointing earnings and waning investor confidence create headwinds. The Adcock Ingram acquisition remains a key catalyst, but its success is uncertain, making this a high-risk, high-reward investment.

View Natco Pharma News Sentiment Analysis

Neuland Laboratories

News based Sentiment: MIXED

September presented a mixed bag for Neuland Laboratories, with disappointing earnings figures countered by significant export growth, a new manufacturing facility coming online, and positive analyst sentiment. While short-term profitability is down, the company appears well-positioned to benefit from broader industry trends and strategic initiatives, making it a cautiously optimistic investment.

View Neuland Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Natco Pharma vs Neuland Laboratories

MetricNATCOPHARMNEULANDLAB
Market Information
Market Cap i₹153.24B₹193.78B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i468,66674,223
90 Day Avg. Volume i420,99152,710
Last Close₹842.30₹14,831.00
52 Week Range₹726.80 - ₹1,505.00₹10,190.70 - ₹18,100.00
% from 52W High-44.03%-18.06%
All-Time High₹1,639.00 (Sep 09, 2024)₹18,100.00 (Dec 02, 2024)
% from All-Time High-48.61%-18.06%
Growth Metrics
Quarterly Revenue Growth-0.03%-0.33%
Quarterly Earnings Growth-0.28%-0.86%
Financial Health
Profit Margin (TTM) i0.39%0.13%
Operating Margin (TTM) i0.39%0.05%
Return on Equity (TTM) i0.25%0.17%
Debt to Equity (MRQ) i3.6710.31
Cash & Liquidity
Book Value per Share (MRQ)₹424.69₹1,188.48
Cash per Share (MRQ)₹139.41₹186.76
Operating Cash Flow (TTM) i₹19.26B₹3.44B
Levered Free Cash Flow (TTM) i₹18.85B₹2.60B
Dividends
Last 12-Month Dividend Yield i0.92%0.08%
Last 12-Month Dividend i₹8.00₹12.00

Valuation & Enterprise Metrics Analysis: Natco Pharma vs Neuland Laboratories

MetricNATCOPHARMNEULANDLAB
Price Ratios
P/E Ratio (TTM) i9.03109.62
Forward P/E i20.7339.91
PEG Ratio i-0.32-1.28
Price to Sales (TTM) i3.4914.68
Price to Book (MRQ) i2.0112.71
Market Capitalization
Market Capitalization i₹153.24B₹193.78B
Enterprise Value i₹132.71B₹195.55B
Enterprise Value Metrics
Enterprise to Revenue i3.0214.70
Enterprise to EBITDA i6.7684.10
Risk & Other Metrics
Beta i0.190.01
Book Value per Share (MRQ) i₹424.69₹1,188.48

Financial Statements Comparison: Natco Pharma vs Neuland Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)NATCOPHARMNEULANDLAB
Revenue/Sales i₹13.29B₹2.93B
Cost of Goods Sold i₹2.33B₹1.53B
Gross Profit i₹10.96B₹1.40B
Research & Development iN/AN/A
Operating Income (EBIT) i₹5.13B₹142.99M
EBITDA i₹6.33B₹423.45M
Pre-Tax Income i₹5.72B₹175.70M
Income Tax i₹916.00M₹36.70M
Net Income (Profit) i₹4.80B₹139.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)NATCOPHARMNEULANDLAB
Cash & Equivalents i₹1.20B₹1.32B
Total Current Assets i₹52.70B₹11.39B
Total Current Liabilities i₹9.44B₹4.66B
Long-Term Debt i₹46.00M₹1.09B
Total Shareholders Equity i₹76.12B₹15.25B
Retained Earnings i₹62.47B₹9.95B
Property, Plant & Equipment i₹474.00M₹6.74B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)NATCOPHARMNEULANDLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNATCOPHARMNEULANDLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i468,66674,223
Average Daily Volume (90 Day) i420,99152,710
Shares Outstanding i179.11M12.83M
Float Shares i83.17M7.19M
% Held by Insiders i0.51%0.38%
% Held by Institutions i0.13%0.25%

Dividend Analysis & Yield Comparison: Natco Pharma vs Neuland Laboratories

MetricNATCOPHARMNEULANDLAB
Last 12-Month Dividend i₹8.00₹12.00
Last 12-Month Dividend Yield i0.92%0.08%
3-Year Avg Annual Dividend i₹6.50₹12.00
3-Year Avg Dividend Yield i0.24%0.20%
3-Year Total Dividends i₹19.50₹36.00
Ex-Dividend DateAug 19, 2025Jul 18, 2025